December 06, 2011
Alkem Laboratories Ltd. on Tuesday moved to block Shire Canada Inc.'s voluntary dismissal of its Illinois suit accusing the drugmaker of infringing its patents for kidney failure treatment Fosrenol, saying the dismissal would delay Alkem from getting its generic to market.